Results 11 to 20 of about 734,075 (399)
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update
Drugs, 2021 Pseudomonas aeruginosa is a Gram-negative bacterial pathogen that is a common cause of nosocomial infections, particularly pneumonia, infection in immunocompromised hosts, and in those with structural lung disease such as cystic fibrosis. Epidemiological
D. Reynolds, M. Kollef
semanticscholar +1 more source
Pseudomonas aeruginosa: An Audacious Pathogen with an Adaptable Arsenal of Virulence Factors
International Journal of Molecular Sciences, 2021 Pseudomonas aeruginosa is a dominant pathogen in people with cystic fibrosis (CF) contributing to morbidity and mortality. Its tremendous ability to adapt greatly facilitates its capacity to cause chronic infections.
Irene Jurado-Martín +2 more
semanticscholar +1 more source
Carbapenemase-producing Pseudomonas aeruginosa –an emerging challenge
Emerging Microbes and Infections, 2022 Carbapenem-resistant Pseudomonas aeruginosa (CR-PA) is a major healthcare-associated pathogen worldwide. In the United States, 10–30% of P. aeruginosa isolates are carbapenem-resistant, while globally the percentage varies considerably.
F. Tenover, D. Nicolau, C. Gill
semanticscholar +1 more source
Frontiers in Microbiology, 2021 Pseudomonas aeruginosa is the most prevalent bacterial species that contribute to cystic fibrosis (CF) respiratory failure. The impaired function of CF transmembrane conductance regulator leads to abnormal epithelial Cl–/HCO3– transport and acidification
Qiao Lin +2 more
doaj +1 more source
Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa
Infectious Disease and Therapy, 2022 Multidrug-resistant (MDR) and extensively drug-resistant (XDR) Pseudomonas aeruginosa isolates are frequent causes of serious nosocomial infections that may compromise the selection of antimicrobial therapy. The goal of this review is to summarize recent
Ashlan J. Kunz Coyne +4 more
semanticscholar +1 more source
Frontiers in Cellular and Infection Microbiology, 2022 Pseudomonas aeruginosa is an opportunistic pathogen causing nosocomial infections in severely ill and immunocompromised patients. Ubiquitously disseminated in the environment, especially in hospitals, it has become a major threat to human health due to ...
Chongbing Liao +4 more
semanticscholar +1 more source
Mobile Carbapenemase Genes in Pseudomonas aeruginosa
Frontiers in Microbiology, 2021 Carbapenem-resistant Pseudomonas aeruginosa is one of the major concerns in clinical settings impelling a great challenge to antimicrobial therapy for patients with infections caused by the pathogen.
Eun-Jeong Yoon, S. Jeong
semanticscholar +1 more source
Molecular detection and antimicrobial activity of Endophytic fungi isolated from a medical plant Rosmarinus officinalis [PDF]
Vol 23, 2020, 14, 2023 Endophytes are tiny organisms present in living tissues of distinct plants and have been extensively studied for their endophytic microbial complement. Roots of Rosmarinus officinalis were subjected to the isolation of endophytic fungi and screened for antimicrobial activity against Gram-positive (Staphylococcus aureus and Bacillus subtilis) and Gram ...
arxiv +1 more source
Advanced Materials Interfaces, EarlyView., 2023 This review discusses the use of Surface‐Enhanced Raman Spectroscopy (SERS) combined with Artificial Intelligence (AI) for detecting antimicrobial resistance (AMR). Various SERS studies used with AI techniques, including machine learning and deep learning, are analyzed for their advantages and limitations.
Zakarya Al‐Shaebi +4 more
wiley +1 more source
Respiratory Research, 2021 Background Pseudomonas aeruginosa is one of the commonest bacteria colonizing the airway in patients with non-cystic fibrosis bronchiectasis. Pseudomonas aeruginosa colonization is associated with poor outcomes in patients with bronchiectasis, including ...
Wang Chun Kwok +4 more
doaj +1 more source